Pathological autoantibodies in cardiomyopathy

Autoimmunity

Volumn 41, Issue 6, 2008, Pages 454-461

  Jahns, Roland ^a   Boivin, Valérie ^a   Schwarzbach, Valentin ^a   Ertl, Georg ^a   Lohse, Martin ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Antibody autoantibody; Beta adrenergic receptor; Cardiac antigens; Dilated cardiomyopathy; Receptor antibodies; Self antigen

Indexed keywords

ACTIN; ADENINE NUCLEOTIDE TRANSLOCASE; ADENYLATE CYCLASE; ATRIAL NATRIURETIC FACTOR; AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR; BRAIN NATRIURETIC PEPTIDE; CARDIAC MYOSIN; CARDIOTOXIN; CASPASE 12; CASPASE 3; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; HEART ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE P38; MUSCARINIC M2 RECEPTOR; MYOSIN ANTIBODY; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; PROTEIN KINASE (CALCIUM,CALMODULIN) II; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TROPONIN; TROPONIN I; TROPONIN T;

ANTIBODY TITER; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CHAGAS DISEASE; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC VALUE; DISEASE COURSE; ENZYME ACTIVATION; GENETIC PREDISPOSITION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; HUMORAL IMMUNITY; HYPOTHESIS; IMMUNOADSORPTION; IMMUNOPATHOGENESIS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SCREENING TEST; SIGNAL TRANSDUCTION; TRYPANOSOMA CRUZI; VIRUS PATHOGENESIS;

ANIMALS; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOIMMUNITY; CARDIOMYOPATHY, DILATED; HUMANS; MYOCARDIUM;

EID: 51849148491     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802031603     Document Type: Article

References (69)

1. American Heart Association (2007) Dallas; Heart disease and stroke statistics - 2007 update. Circulation, 115, pp. e69-e171.
2. Richardson, P., McKenna, W., Bristow, M., Maisch, B., Mautner, B., O'Connell, J., Olsen, I., Thiene, G., Goodwin, J. Gyarfas, I. et al. (1996) Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Circulation, 93, pp. 841-842.
3. Morita, H., Seidman, J. and Seidman, CE (2005) Genetic causes of human heart failure. J Clin Invest, 115, pp. 518-526.
4. Fabrizio, L. and Regan, TJ (1994) Alcoholic cardiomyopathy. Cardiovasc Drugs Ther, 8, pp. 89-94.
5. Chien, KR (2000) Myocyte survival pathways and cardiomyopathy: Implications for trastuzumab cardiotoxicity. Semin Oncol, 27, pp. 9-17.
6. MacLellan, WR and Lusis, AJ (2003) Dilated cardiomyopathy: Learning to live with yourself. Nat Med, 9, pp. 1455-1456.
7. Freedman, NJ and Lefkowitz, RJ (2004) Anti-beta1-adrenergic receptor antibodies and heart failure: Causation, not just correlation. J Clin Invest, 113, pp. 1379-1382.
8. Jahns, R., Boivin, V. and Lohse, MJ (2006) Beta1-adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy. Trends Cardiovasc Med, 16, pp. 20-24.
9. Kuhl, U., Pauschinger, M., Seeberg, B., Lassner, D., Noutsias, M., Poller, W. and Schultheiss, HP (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation, 112, pp. 1965-1970.
10. Limas, CJ (1997) Cardiac autoantibodies in dilated cardiomyopathy. Circulation, 95, pp. 1979-1980.
11. Luppi, P., Rudert, WA, Zanone, MM, Stassi, G., Trucco, G., Finegold, D., Boyle, GJ, Del Nido, P, McGowan, FX and Trucco, M. (1998) Idiopathic dilated cardiomyopathy. A superantigen-driven autoimmune disease. Circulation, 98, pp. 777-785.
12. Mahrholdt, H., Wagner, A., Deluggi, CC, Kispert, E., Hager, S., Meinhardt, G., Vogelsberg, H., Fritz, P., Dippon, J. Bock, C-T et al. (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation, 114, pp. 1581-1590.
13. Schultheiss, HP, Kuhl, U., Janda, I., Melzner, B., Ulrich, G. and Morad, M. (1988) Antibody-mediated enhancement of calcium permeability in cardiac myocytes. J Exp Med, 168, pp. 2102-2109.
14. Pohlner, K., Portig, I., Pankuweit, S., Lottspeich, F. and Maisch, B. (1997) Identification of mitochondrial antigens recognized by the antibody in sera of patients with dilated cardiomyopathy by two-dimensional gel electrophoresis and protein sequencing. Am J Cardiol, 80, pp. 1040-1045.
15. Neumann, DA, Burek, CL, Baughman, KL, Rose, NR and Herskowitz, A. (1990) Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol, 16, pp. 839-846.
16. Caforio, AL, Mahon, NJ, Tona, F. and McKenna, WJ (2002) Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: Pathogenetic and clinical significance. Eur J Heart Fail, 4, pp. 411-417.
17. Okazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M., Hiai, H., Matsumori, A. Minato, N. et al. (2003) Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med, 9, pp. 1477-1483.
18. Goser, S., Andrassy, M., Buss, SJ, Leuschner, F., Volz, CH, Ottl, R., Zittrich, S., Blaudeck, N., Hardt, SE Pfitzer, G. et al. (2006) Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation, 114, pp. 1693-1702.
19. Li, Y., Heuser, JS, Cunningham, LC, Kosanke, SD and Cunningham, MW (2006) Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol, 177, pp. 8234-8240.
20. Magnusson, Y., Wallukat, G., Waagstein, F., Hjalmarson, Å and Hoebeke, J. (1994) Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta1-adrenoceptor with positive chronotropic effect. Circulation, 89, pp. 2760-2767.
21. Jahns, R., Boivin, V., Siegmund, C., Inselmann, G., Lohse, MJ and Boege, F. (1999) Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation, 99, pp. 649-654.
22. Fu, LXM, Magnusson, Y., Bergh, CH, Waagstein, F., Hjalmarson, Å and Hoebeke, J. (1993) Localization of a functional autoimmune epitope on the second extracellular loop of the human muscarinic acetylcholine receptor 2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest, 91, pp. 1964-1968.
23. Limas, CJ (1996) Autoimmunity in dilated cardiomyopathy and the major histocompatibility complex. Int J Cardiol, 54, pp. 113-116.
24. Limas, CJ, Iakovis, P., Anyfantakis, A., Kroupis, C. and Cokkinos, DV (2004) Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy. Am J Cardiol, 93, pp. 1189-1191.
25. Caforio, AL, Mahon, NG, Kamran Baig, M, Tona, F., Murphy, RT, Elliott, PM and McKenna, WJ (2007) Prospective familial assessment in dilated cardiomyopathy: Cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation, 115, pp. 76-83.
26. Hoebeke, J. (1996) Structural basis of autoimmunity against G protein-coupled membrane receptors. Int J Cardiol, 54, pp. 103-111.
27. Mobini, R., Maschke, H. and Waagstein, F. (2004) New insights into the pathogenesis of dilated cardiomyopathy: Possible underlying mechanisms and therapy. Autoimmun Rev, 3, pp. 277-284.
28. Ferrari, I., Levin, M., Wallukat, G., Elies, R., Lebesgue, D., Chiale, P., Elizari, M., Rosenbaum, M. and Hoebeke, J. (1995) Molecular mimicry between the immunodominant ribosomal protein PO of Trypanosoma cruzi and a functional epitope on the human beta1-adrenergic receptor. J Exp Med, 182, pp. 59-65.
29. Smulski, C., Labovsky, V., Levy, G., Hontebeyrie, M., Hoebeke, J. and Levin, MJ (2006) Structural basis of the cross-reaction between an antibody to the Trypanosoma cruzi ribosomal P2beta protein and the human beta1-adrenergic receptor. FASEB J, 20, pp. 1396-1406.
30. Magnusson, Y., Hjalmarson, Å and Hoebeke, J. (1996) Beta1-adrenoceptor autoimmunity in cardiomyopathy. Int J Cardiol, 54, pp. 137-141.
31. Rose, NR (2001) Infection, mimics, and autoimmune disease. J Clin Invest, 107, pp. 943-944.
32. Eriksson, U., Ricci, R., Hunziker, L., Kurrer, MO, Oudit, GY, Watts, TH, Sonderegger, I., Bachmaier, K., Kopf, M. and Penninger, JM (2003) Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med, 9, pp. 1484-1490.
33. Witebsky, E., Rose, NR, Terplan, K., Paine, JR and Egan, RW (1957) Chronic thyreoiditis and auto-immunization. J Am Med Assoc, 164, pp. 1439-1447.
34. Rose, NR and Bona, C. (1993) Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today, 14, pp. 426-430.
35. Portig, I., Pankuweit, S. and Maisch, B. (1997) Antibodies against stress proteins in sera of patients with dilated cardiomyopathy. J Mol Cell Cardiol, 29, pp. 2245-2251.
36. Okazaki, T. and Honjo, T. (2005) Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy. Trends Mol Med, 11, pp. 322-326.
37. Schulze, K., Witzenbichler, B., Christmann, C. and Schultheiss, HP (1999) Disturbance of myo-cardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotid translocator. Cardiovasc Res, 44, pp. 91-100.
38. Khoynezhad, A. (2007) Promising aspects and caveats of studies on anti-apoptotic therapies in patients with heart failure. Eur J Heart Fail, 9, pp. 120-123.
39. Nishimura, H., Okazaki, T., Tanaka, Y., Natakani, K., Hara, M. Matsumori, A. et al. (2001) Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science, 291, pp. 319-322.
40. Caforio, AL, Grazzini, M., Mann, J., Keeling, PJ, Botazzo, G., McKenna, WJ and Schiaffino, S. (1992) Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation, 85, pp. 1734-1742.
41. Lauer, B., Schannwell, M., Kuhl, U., Strauer, BE and Schultheiss, HP (2001) Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol, 35, pp. 11-18.
42. Neu, N., Ploier, B. and Ofner, C. (1990) Cardiac myosin-induced myocarditis: Heart autoantibodies are not involved in the induction of the disease. J Immunol, 145, pp. 4094-4100.
43. Jane-wit, D., Altuntas, CZ, Johnson, JM, Yong, S., Wickley, PJ, Clark, P., Wang, Q., Popovic, ZB, Penn, MS Damron, DS et al. (2007) Beta1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis. Circulation, 116, pp. 1-12.
44. Lohse, MJ, Engelhardt, S. and Eschenhagen, T. (2003) What is the role of beta-adrenergic signaling in heart failure?. Circ Res, 93, pp. 896-906.
45. Matsui, S., Fu, M., Shimizu, M., Fukuoka, T., Teraoka, K., Takekoshi, N., Murakami, E. and Hjalmarson, Å (1995) Dilated cardiomyopaty defines serum autoantibodies against G protein-coupled cardiovascular receptors. Autoimmunity, 21, pp. 85-88.
46. Wang, WZ, Zhao, RR, Wu, BW, Jin, XH, Zuh, L., Hjalmarson, Å and Fu, LXM (1996) Effects of anti-peptide antibodies against human M2 muscarinic receptors on cardiac function of rats in vivo. Blood Press, 3, pp. 25-27.
47. Baba, A., Yoshikawa, T., Fukuda, Y., Sugiyama, T., Shimada, M., Akaishi, M., Tsuchimoto, K., Ogawa, S. and Fu, M. (2004) Autoantibodies against M2-muscarinic acetylcholine receptors: New upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J, 25, pp. 1108-1115.
48. Iwata, M., Yoshikawa, T., Baba, A., Anzai, T., Mitamura, H. and Ogawa, S. (2001) Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol, 37, pp. 418-424.
49. Christ, T., Schindelhauer, S., Wettwer, E., Wallukat, G. and Ravens, U. (2006) Interaction between autoantibodies against the beta1-adrenoceptor and isoprenaline in enhancing L-type Ca2+ current in rat ventricular myocytes. J Mol Cell Cardiol, 41, pp. 716-723.
50. Iwata, M., Yoshikawa, T., Baba, A., Anzai, T., Nakamura, I., Wainai, Y., Takahashi, T. and Ogawa, S. (2001) Autoimmunity against the second extracellular loop of beta1-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo. Circ Res, 88, pp. 578-586.
51. Jahns, R., Siegmund, C., Jahns, V., Reilander, H., Maidhof, A., Muller-Esterl, W., Lohse, MJ and Boege, F. (1996) Probing human beta1- and beta2-adrenoceptors with domain-specific fusion protein antibodies. Eur J Pharmacol, 316, pp. 111-121.
52. Jahns, R., Boivin, V., Krapf, T., Wallukat, G., Boege, F. and Lohse, MJ (2000) Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies. J Am Coll Cardiol, 36, pp. 1280-1287.
53. Buvall, L., Tang, MS, Isic, A., Andersson, B. and Fu, M. (2007) Antibodies against the beta1-adrenergic receptor induce progressive development of cardiomyopathy. J Mol Cell Cardiol, 42, pp. 1001-1007.
54. Buvall, L., Bollano, E., Chen, J., Shultze, W. and Fu, M. (2005) Phenotype of early cardiomyopathic changes induced by active immunization of rats with a synthetic peptide corresponding to the second extracellular loop of the human beta1-adrenergic receptor. Clin Exp Immunol, 143, pp. 209-215.
55. Jahns, R., Boivin, V., Hein, L., Triebel, S., Angermann, CE, Ertl, G. and Lohse, MJ (2004) Direct evidence for a beta1-adrenergic receptor directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest, 113, pp. 1419-1429.
56. Engelhardt, S., Hein, L., Wiesmann, F. and Lohse, MJ (1999) Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA, 96, pp. 7059-7064.
57. Woodiwiss, AJ, Tsotetsi, OJ, Sprott, S., Lancaster, EJ, Mela, T., Chung, ES, Meyer, TE and Norton, GR (2001) Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction. Circulation, 103, pp. 155-160.
58. Nikolaev, VO, Boivin, V., Stork, S., Angermann, CE, Ertl, G., Lohse, MJ and Jahns, R. (2007) A novel fluorescent method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure. J Am Coll Cardiol, 50, pp. 423-431.
59. Ryu, KH, Tanaka, N., Dalton, N., Mao, L., Rockman, HA, Milano, CA and Ross, JJ (1997) Force-frequency relations in the failing rabbit heart and responses to adrenergic stimulation. J Card Fail, 3, pp. 27-39.
60. Mao, W., Fukuoka, S., Iwai, C., Liu, J., Sharma, VK, Sheu, S., Fu, M. and Liang, C. (2007) Cardiomyocyte apoptosis in autoimmune cardiomyopathy: Mediated via endoplasmic reticulum stress and exaggerated by norepinephrine. Am J Physiol Heart Circ Physiol, 293, pp. H1636-H1646.
61. Jahns, R., Boivin, V., Siegmund, C., Boege, F., Lohse, MJ and Inselmann, G. (1999) Activating beta1-adrenoceptor antibodies are not associated with cardiomyopathies secondary to valvular or hypertensive heart disease. J Am Coll Cardiol, 34, pp. 1545-1551.
62. Stork, S., Boivin, V., Horf, R., Hein, L., Lohse, MJ, Angermann, CE and Jahns, R. (2006) Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J, 152, pp. 697-704.
63. Limas, CJ, Goldenberg, IF and Limas, C. (1992) Assessment of immune modulation of beta-adrenergic pathways in human dilated cardiomyopathy: Influence of methodologic factors. Am Heart J, 123, pp. 967-970.
64. Wallukat, G., Wollenberger, A., Morwinski, R. and Pitschner, HF (1995) Anti-beta1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: Mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol, 27, pp. 397-406.
65. Chiale, PA, Ferrari, I., Mahler, E., Vallazza, MA, Elizari, MV, Rosenbaum, MB and Levin, MJ (2001) Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation, 103, pp. 1765-1771.
66. Hershko, AY and Naparstek, Y. (2005) Removal of pathogenic autoantibodies by immunoadsorption. Ann N Y Acad Sci, 1051, pp. 635-646.
67. Wallukat, G., Muller, J. and Hetzer, R. (2002) Specific removal of beta1-adrenergic antibodies directed against cardiac proteins from patients with idiopathic dilated cardiomyopathy. N Engl J Med, 347, p. 1806.
68. Staudt, A., Hummel, A., Ruppert, J., Dorr, M., Trimpert, C., Birkenmeier, K., Krieg, T., Staudt, Y. and Felix, SB (2006) Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study. Am Heart J, 152, pp. 712e1-712e6.
69. Anderton, SM (2001) Peptide-based immunotherapy of autoimmunity: A path of puzzles, paradoxes, and possibilities. Immunology, 104, pp. 367-376.